RA

Rayont IncOOTC RAYT Stock Report

Last reporting period 31 Mar, 2023

Updated 12 Nov, 2024

Last price

Market cap $B

0.001

Micro

Exchange

OOTC - OTC

RAYT Stock Analysis

RA

Uncovered

Rayont Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

9/100

Low score

Market cap $B

0.001

Dividend yield

Shares outstanding

50.164 B

Rayont, Inc. engages in the provision of education, business, technology, healthcare and financial services. The company is headquartered in Palo Alto, California and currently employs 58 full-time employees. The company went IPO on 2012-06-14. The firm focuses on healthcare including the manufacturing of alternative medicine products and services. The firm also invested in a cancer treatment technology. The firm produces a range of products including proteins, green blends, sports nutrition, weight management and maintenance and health and wellness products. The Company’s brands include NVA, Wonderfoods, Healthscript, Total Vita, NPM, Rosa Naturels, No More Knots, Tugun Compounding, Skin DNA Testing and Biomimic. The firm's subsidiaries include Rayont (Australia) Pty Ltd, Rayont International Ltd Labuan Malaysia, Rayont Malaysia Pty Ltd and Prema Life (United States) Inc.

View Section: Eyestock Rating